Table: Shin Nippon Biomedical -2021/22 group results

Shin Nippon Biomedical Laboratories

06/05/2022 07:00

May 6 (Reuters)- 
          Shin Nippon Biomedical Laboratories Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           17.75           15.11          19.60         9.50    
               (+17.5 pct)     (+3.8 pct)     (+10.4 pct)  (+19.3 pct) 
  Operating        4.20            2.53           5.00         2.45    
               (+65.9 pct)     (+13.5 pct)    (+19.2 pct)  (+24.4 pct) 
  Recurring        7.08            3.65           6.00         2.95    
               (+94.2 pct)     (+16.8 pct)    (-15.2 pct)  (+16.6 pct) 
  Net
  Net              7.13            3.66           4.30         2.05    
               (+94.6 pct)     (+43.6 pct)    (-39.7 pct)  (-41.5 pct) 
  EPS          171.20 yen       87.95 yen     103.28 yen    49.24 yen  
  Ann Div       40.00 yen       20.00 yen      40.00 yen               
  -Q2 Div          NIL             NIL         20.00 yen               
  -Q4 Div       40.00 yen       20.00 yen      20.00 yen               
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T